Svalinn Therapeutics
Developing a safe radical cure for Malaria.
Malaria threatens 40% of the world’s population.
WHO estimates that 274,000 children under the age of 5 died from Malaria in 2019 alone.
Genetic barriers to current medicines:
Unfortunately, 10-20% of the affected population has an enzyme variant preventing them from taking drugs needed to cure certain diseases. They are likely to suffer lifelong recurrences of their disease and can pass it on to others.
